FDA Recalls Injectable Medication Due to Sterility Assurance Failure
Carolina Infusion's QUAD-MIX 30/2/60/0.15 injectable (Lot 08022022@12) is recalled nationwide because the manufacturer failed to assure sterility. Patients and healthcare providers should not use affected vials and should contact the manufacturer.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall for injectable drug with failure to assure sterility; no illnesses or injuries reported, but non-sterile injectables pose high risk of infection and represent a risk-of-harm product.
Plain-English summary
QUAD-MIX 30/2/60/0.15 Injectable is a prescription medication supplied in 5 mL vials by Carolina Infusion LLC, located in Ridgeland, South Carolina. The recall covers Lot 08022022@12, which had a Beyond Use Date of October 1, 2022.
The U.S. Food and Drug Administration has classified this as a Class II recall due to the manufacturer's failure to assure that the affected vials meet sterility standards. Sterile injectable medications must be free from contamination and must meet established manufacturing controls for patient safety.
The affected product was distributed nationwide. Patients and healthcare providers who have received or administered QUAD-MIX from the recalled lot should contact Carolina Infusion LLC immediately. Patients should not use vials from this lot and should consult their healthcare provider about any concerns or symptoms following use.
The recalled product
- Product
- QUAD-MIX 30/2/60/0.15 Injectable, 5 ML vial, Rx only, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936.
- Manufacturer
- Carolina Infusion
- Hazard
- lack-of-sterility
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: 08022022@12
- BUD: 10/01/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27